Stay updated with breaking news from Enforcement Report. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
USFDA noted that the New Jersey-based Biocon Pharma Inc is recalling the affected lot due to ‘Failed Impurities/Degradation Specifications: High Out Of Specification degradation results’.
Agencies Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing. As per the US Food and Drug Administration’s Enforcement Report, the US-based arm of Sun Pharmaceutical Industries is recalling lots of Diltiazem Hydrochloride extended-release capsules
The Mumbai-based drug major had produced the lot at its Halol-based manufacturing facility in Gujarat. The affected lot was later distributed in the market by its US-based unit.
Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.
Download logoThe increase in environmental incidents in the last year resulted in devastating impacts on the environment bringing into question the